Introduction
Advanced chronic kidney disease (CKD) and, to a much greater extent, end-stage renal disease (ESRD) are two of the most striking examples of health disparities. Both advanced CKD and ESRD are marked by inequalities in the incidence and prevalence, risk factors and disease treatment across different races and ethnicities and socioeconomic status (SES). In the United States, the burden of advanced CKD disproportionately affects African Americans/blacks despite similar rates among racial/ ethnic groups in early stages of CKD [1] [2] [3] . The incidence of ESRD is 3.4 times higher in blacks compared with whites 3 . The high incidence of ESRD among blacks has been attributed to the high prevalence of major CKD risk factors including hypertension 4, 5 , diabetes 6, 7 and obesity 8 ; genetic predisposition [9] [10] [11] ; low SES 12 and inequities in access to and quality of CKD care 13 .
Race and SES are strongly correlated in the United States, and certain racial/ethnic minorities are more likely to be classified as having low SES. Income (or poverty status) is one of the most commonly used metrics to ascertain SES. In 2011, 27.6% of blacks lived below the US federal poverty level compared with 9.8% of non-Hispanic whites 14 . Other measures of SES commonly used in research include education attained and occupation. However, it is important to recognise the complexity of measuring an individual's SES, and none of these metrics may be sufficient to fully capture it. Communitylevel SES factors such as neighbourhood poverty and residential segregation have also been used in research 15, 16 . These factors may be equally or more important social determinants of health, especially in African Americans, than individuallevel factors such as income. Low SES individuals/families tend to cluster, creating areas of high poverty density 17 . Poverty density directly impacts the community resources available to an individual. An individual with a low income living in or in close proximity to higher SES neighbourhoods may still have access to better schools, healthy foods, sanitary housing conditions, safe parks for recreation and quality health care as opposed to someone with higher income who is living in a poverty dense area 17 . It is also conceivable that individual-level SES factors may be modified by community-level SES factors.
Low SES is independently associated with ESRD incidence 18, 19 . SES may influence ESRD risk through a number of mechanisms. Individuals *Corresponding author Email: dcrews1@jhmi.edu living in poverty have a high burden of acute and chronic social and psychosocial stressors 20, 21 , which may in turn lead to unhealthy behaviours and impact their ability to access health information or services. Individuals living in poverty are also more likely to be exposed to toxins or pollutants from their physical environment 22 . Additionally, the negative health consequences of being persistently disadvantaged may be cumulative 21 . The aim of this review was to discuss racial and socioeconomic disparities in ESRD in the United States.
Discussion
The authors have referenced some of their own studies in this review. These referenced studies have been conducted in accordance with the Declaration of Helsinki (1964) , and the protocols of these studies have been approved by the relevant ethics committees related to the institution in which they were performed. All human subjects, in these referenced studies, gave informed consent to participate in these studies.
Race and ESRD
Blacks have a disproportionately high burden of CKD in the United States 3 . Racial disparities in access to care and quality of care in advanced CKD and treated ESRD have also been well documented. Blacks are less likely than whites to receive pre-ESRD care 23 and are more likely to be referred late for nephrology care 24 , both of which are associated with worse survival 25, 26 . Blacks are also less likely to utilise home dialysis therapies 27 and have significantly lower rates of kidney transplantation 28, 29 . Furthermore, blacks with ESRD are more likely to start haemodialysis without an arteriovenous fistula 30 , have untreated and higher intact parathyroid hormone levels 31 and receive inadequate dialysis 32 -all indices associated with poorer outcomes.
Despite the higher rates of progression to ESRD and inequalities in care, blacks with treated ESRD have a paradoxically better survival when compared with whites -a robust observation as elucidated by numerous studies [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] . The reason for this survival paradox is not well understood.
Biological theories include a more favourable nutritional and/or inflammatory profile 43 , resilience to inflammation in blacks 47 and differential sensitivity to dialysis dose 33 . Others postulate that improved access to health care afforded by the US Centres for Medicare and Medicaid Services (CMS) ESRD insurance coverage program may confer a survival benefit to black patients who are more likely to be uninsured prior to dialysis initiation 16 . This provision of health insurance coverage improves access to care and medication as well as facilitates nutrition and social work counselling, which may have been previously lacking in these patients. A recent study by Kucirka et al. 48 challenged the robustness of this racial survival paradox by demonstrating that it was not present across all age strata. In their study, 18-to 30-yearold dialysis patients had a nearly twofold increased risk of death compared with whites. The authors postulated that this younger dialysis population in the United States might be particularly vulnerable to racial and socioeconomic disparities in CKD care and ESRD management, which may be offset by Medicare entitlement in the older adult population. 15 . In a study of three southeastern US states, they showed that increasing neighbourhood poverty was associated with increasing risk of ESRD for both African Americans and whites, but the effect was greatest for African Americans 15 . This may indicate that African Americans and whites have differential exposure to the negative health consequences of low SES. Low SES may also potentiate differences in underlying biology between African Americans and periods, where exposure to psychosocial and physical factors may be particularly relevant; and further research is also needed to advance our understanding of gene-environment interactions in CKD. Atlas whites. The discovery of the association of apolipoprotein L1 (APOL1) risk variant status with hypertensive and HIV-related kidney disease suggest that a gene-environment interaction is very plausible [9] [10] [11] . 16 . They also examined the race-survival association by the dissimilarity index, which measures the severity of residential segregation, and demonstrated that blacks who were living in more racially segregated counties had a higher hazard of death while the risk of death for whites was unchanged. This finding suggests that communitylevel SES factors, such as neighbourhood of residence and living conditions, may play a more important role in African Americans than individuallevel factors such as income. It is, however, important to note that in these latter studies the average age of the incident dialysis cohorts was 60 years or above, and none of these studies stratified by age group. This could possibly mask the effects of SES and access to care factors, which could be more racially disparate in a young adult dialysis cohort because of Medicare eligibility among older patients 48 .
Race, SES and ESRD incidence

Race, SES and ESRD survival
Few studies have examined the interaction of race and SES in ESRD survival. Earlier population-based studies in the United States found an association between low SES and higher mortality and indicated
Conclusion
In summary, the interplay between race and SES in ESRD risk and outcomes is complex and not well understood. Socioeconomic factors, both community and individual level, are likely to contribute to racial disparities in ESRD risk through many different mechanisms. Low SES also appears to have a differential effect in Africans American compared with whites, possibly through a dose relationship (years of exposure) and/ or by potentiating racial differences in biology. Studies are needed to address whether there may be a cumulative effect on the chronically disadvantaged. Future studies examining the role of SES in ESRD risk and outcomes should also include children and young adults who may be particularly vulnerable to the negative health consequences of low SES. Furthermore, studies should also include the pre-and perinatal
